Sound Income Strategies’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-6
Closed -$1.1K – 686
2026
Q1
$1.1K Hold
6
– – ﹤0.01% 2285
2025
Q4
$987 Buy
+6
New +$980 ﹤0.01% 2295
2024
Q1
– Sell
-40
Closed -$10.4K – 1362
2023
Q4
$10.4K Buy
+40
New +$9.82K ﹤0.01% 724
2021
Q2
– Sell
-39
Closed -$10.9K – 891
2021
Q1
$10.9K Buy
39
+20
+105% +$5.39K ﹤0.01% 465
2020
Q4
$5K Hold
19
– – ﹤0.01% 576
2020
Q3
$5K Buy
+19
New +$5.3K ﹤0.01% 535
2019
Q1
– Sell
-20
Closed -$6K – 677
2018
Q4
$6K Hold
20
– – ﹤0.01% 405
2018
Q3
$7K Buy
20
+19
+1,900% +$6.54K ﹤0.01% 404
2018
Q2
$0 Buy
+1
New +$281 ﹤0.01% 626

Other funds holding BIIB

Sound Income Strategies's BIIB Position: Q2 2026 in Review

Sound Income Strategies sold out of Biogen (BIIB) in Q2 2026, closing a stake of 6 shares — an estimated $1.1K sold.

Sound Income Strategies first reported a position in BIIB in Q2 2018 and held it in 9 quarters. The position peaked at $10.9K in Q1 2021. 1,046 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Sound Income Strategies reported no remaining Biogen position as of Q2 2026 after selling out during the quarter.
  • Sound Income Strategies sold 6 Biogen shares in Q2 2026, an estimated $1.1K.
  • Sound Income Strategies first reported a position in Biogen in Q2 2018 and held it in 9 quarters.
  • Sound Income Strategies's Biogen position peaked at $10.9K in Q1 2021.
  • 1,046 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Sound Income Strategies's 13F filing for Q2 2026, filed 20 Jul 2026.